Related Experiment Videos
[Renal function in heart failure patients. Prognostic influence and therapeutic implications]
J R González-Juanatey1, L Grigorián, F Otero Raviña
1Servicio de Cardiología, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, A Coruña, Spain. jose.ramon.gonzalez.juanatey@sergas.es
Medicina Clinica
|May 23, 2009
Summary
Renal failure is common in heart failure patients, increasing complexity and death risk. Early diagnosis and careful management, including renin-angiotensin-aldosterone system blockers, are crucial for better outcomes.
Area of Science:
- Cardiology
- Nephrology
- Internal Medicine
Context:
- A strong link exists between kidney function and cardiovascular health.
- Renal dysfunction exacerbates cardiovascular disease, while vascular issues raise kidney failure risk.
- These connections are particularly pronounced in heart failure patients.
Purpose:
- To review the epidemiology, clinical presentation, and diagnostic, therapeutic, and prognostic implications of renal failure in heart failure patients.
- To highlight the increased prevalence and complexity of renal failure in heart failure.
- To discuss the impact of renal failure on patient outcomes and treatment strategies.
Summary:
- Renal failure is highly prevalent in heart failure patients, irrespective of ejection fraction.
- This comorbidity presents significant clinical and diagnostic challenges, independently elevating mortality and complication risks.
- Therapeutic strategies, particularly renin-angiotensin-aldosterone system inhibitors, offer prognostic benefits but require close monitoring.
Impact:
- Establishes renal failure as a critical factor in heart failure management.
- Underscores the need for integrated care approaches for patients with cardiorenal syndrome.
- Informs clinical practice regarding diagnosis, treatment, and prognosis in this vulnerable population.
Related Concept Videos
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:11Renal Failure: Dose Adjustments
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...